Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Inhibrx Inc (INBX)

Inhibrx Inc (INBX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 444,631
  • Shares Outstanding, K 39,037
  • Annual Sales, $ 7,230 K
  • Annual Income, $ -81,770 K
  • 60-Month Beta 3.10
  • Price/Sales 64.94
  • Price/Cash Flow N/A
  • Price/Book 17.17
Trade INBX with:

Options Overview Details

View History
  • Implied Volatility 109.01% ( -11.42%)
  • Historical Volatility 105.08%
  • IV Percentile 58%
  • IV Rank 32.47%
  • IV High 222.32% on 06/06/22
  • IV Low 54.53% on 10/01/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 1
  • Volume Avg (30-Day) 12
  • Put/Call OI Ratio 0.10
  • Today's Open Interest 573
  • Open Int (30-Day) 706

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate -0.84
  • Number of Estimates 1
  • High Estimate -0.84
  • Low Estimate -0.84
  • Prior Year -0.55
  • Growth Rate Est. (year over year) -52.73%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.67 +56.32%
on 06/16/22
13.54 -11.45%
on 05/31/22
-1.66 (-12.16%)
since 05/27/22
3-Month
7.67 +56.32%
on 06/16/22
25.77 -53.47%
on 04/04/22
-11.92 (-49.85%)
since 03/29/22
52-Week
7.67 +56.32%
on 06/16/22
47.90 -74.97%
on 11/02/21
-14.79 (-55.23%)
since 06/29/21

Most Recent Stories

More News
Inhibrx, Inc. (INBX) Reports Q1 Loss, Misses Revenue Estimates

Inhibrx, Inc. (INBX) delivered earnings and revenue surprises of -29.03% and 7.10%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

INBX : 11.99 (+5.27%)
RNA : 14.30 (+1.06%)
Cara Therapeutics (CARA) Reports Q1 Loss, Lags Revenue Estimates

Cara (CARA) delivered earnings and revenue surprises of 7.14% and 69.72%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

CARA : 9.60 (+3.67%)
INBX : 11.99 (+5.27%)
KaloBios Pharmaceuticals Inc. (HGEN) Reports Q1 Loss, Misses Revenue Estimates

KaloBios Pharmaceuticals Inc. (HGEN) delivered earnings and revenue surprises of 34.69% and 0.39%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?...

HGEN : 1.8400 (-4.66%)
INBX : 11.99 (+5.27%)
Inhibrx, Inc. (INBX) Soars 15%: Is Further Upside Left in the Stock?

Inhibrx, Inc. (INBX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase...

INBX : 11.99 (+5.27%)
CRMD : 3.59 (+0.84%)
Oversold Conditions For Inhibrx (INBX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical...

INBX : 11.99 (+5.27%)
Oversold Conditions For Inhibrx (INBX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical...

INBX : 11.99 (+5.27%)
Here's What Could Help Inhibrx, Inc. (INBX) Maintain Its Recent Price Strength

Inhibrx, Inc. (INBX) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

INBX : 11.99 (+5.27%)
First Week of December 17th Options Trading For Inhibrx (INBX)

Investors in Inhibrx Inc saw new options become available this week, for the December 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the INBX options chain...

INBX : 11.99 (+5.27%)
Takeda (TAK) CMV Infection Drug Livtencity Gets FDA Approval

The FDA grants approval to the new drug application seeking approval for Takeda's (TAK) maribavir for treating post-transplant cytomegalovirus infection.

ASRT : 2.85 (unch)
TAK : 13.85 (-0.07%)
ISEE : 9.68 (+1.57%)
INBX : 11.99 (+5.27%)
Amryt (AMYT) Skin Disorder NDA Review Gets 3 Months Extension

Amryt (AMYT) is seeking approval for Oleogel-S10 for treating epidermolysis bullosa, a rare genetic skin disorder, in the United States and Europe. The FDA extends the review period for the drug's NDA...

ISEE : 9.68 (+1.57%)
IMAB : 10.88 (-4.23%)
AMYT : 7.09 (-6.96%)
INBX : 11.99 (+5.27%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Inhibrx Inc. is a clinical-stage biotechnology company. The company's pipeline is focused on oncology and orphan diseases. Inhibrx Inc. is based in SAN DIEGO.

See More

Key Turning Points

3rd Resistance Point 13.53
2nd Resistance Point 12.78
1st Resistance Point 12.39
Last Price 11.99
1st Support Level 11.25
2nd Support Level 10.50
3rd Support Level 10.11

See More

52-Week High 47.90
Fibonacci 61.8% 32.53
Fibonacci 50% 27.78
Fibonacci 38.2% 23.04
Last Price 11.99
52-Week Low 7.67

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar